Home » Topics » BioWorld Science

BioWorld Science
RSS

New glutaminyl cyclase inhibitors patented by Academia Sinica, NHRI

March 16, 2020

University of Edinburgh discloses new cyclophilin inhibitors

March 16, 2020

PharmaMar reports promising in vitro study results with Aplidin against coronavirus HCoV-229E

March 16, 2020

See in 3D

March 16, 2020

Researchers develop murine model of CMV infection in pregnancy

March 16, 2020

FDA clears IND for phase I/II trial of Adaptive Phage Therapeutics' PhageBank

March 16, 2020

New approach to cancer immunotherapy identified

March 16, 2020

First-in-human data for (R,R)-penehyclidine fumarate

March 16, 2020

NPSR1 as a novel nonhormonal target in endometriosis

March 16, 2020

Anti-POTEF autoantibodies as new biomarker in primary ovarian insufficiency

March 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.